The Biomanufacturing Blog

Subscribe Here!

No More “What Ifs” - How Nektar Takes the Guesswork Out of Scaling Bioprocesses

Culture's client Nektar Therapeutics is exploring new PEG-based modifications to therapeutic...

Now is the Time to Start Using a Cloud Lab

Is COVID-19 affecting your lab operations? Run bioprocess experiments from your laptop at home...

Scaling Up from Culture’s 250mL Reactors to 5,000L and 50,000L Tanks

Modern Meadow, one of Culture Biosciences’ first customers, is biomanufacturing the next...

Best Practices in Fermentation Bioprocess Development

We spoke with Stefan De Kok, Ph. D., Director of Fermentation at Zymergen, about his experience...

Building a Better Bioreactor: an Interview with our CTO, Matt Ball

In a previous interview with Culture’s CEO and cofounder, Will Patrick, we explored the origins...

Leaving Google to Write Code and Make Lasagna at Culture

 

An interview with Satshabad Khalsa, a Software Engineer at Culture, about his career journey.

High-Throughput DoE Of 52 Parallel Bioreactors Doubles Titer In 1 Week

Data from an ongoing collaboration with Cytovance Biologics to rapidly optimize and scale...

Culture's Founding Story: An Interview with CEO Will Patrick

One year after launching the company, Culture Biosciences’ co-founder and CEO, Will Patrick,...

Analyze All Your High-Throughput Bioreactor Data in the Cloud

Announcing the launch of additional graphing and data visualization features on our website.

Clara Foods™ Approaches Scaling Up by Scaling Down

Ranjan Patnaik, Ph. D., the Chief Technology Officer at Clara Foods, sat down with us to discuss...

1 2 3